Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis

OBJECTIVES: The aim of this study was to compare the clinical effectiveness of tofacitinib and abatacept and clarify the impact of the HLA-DRB1 shared epitope (SE) on responses to these treatments in patients with rheumatoid arthritis (RA). METHODS: After adjustments by propensity score matching, 70...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirose, Wataru, Harigai, Masayoshi, Amano, Koichi, Hidaka, Toshihiko, Itoh, Kenji, Aoki, Kazutoshi, Nakashima, Masahiro, Nagasawa, Hayato, Komano, Yukiko, Nanki, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407060/
https://www.ncbi.nlm.nih.gov/pubmed/34465391
http://dx.doi.org/10.1186/s13075-021-02612-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407060/
https://www.ncbi.nlm.nih.gov/pubmed/34465391
http://dx.doi.org/10.1186/s13075-021-02612-w

Ejemplares similares